SERUM AND CSF CONCENTRATIONS OF MIDAZOLAM AND 1-HYDROXY-MIDAZOLAM IN NEUROSURGICAL PATIENTS WITH EVD

被引：0
|
作者：
MacLaren, Robert [1 ]
Farrar, Julie [2 ]
Stefanos, Sylvia S. [1 ]
Cava, Luis [3 ]
Kiser, Tyree [4 ]
Mueller, Scott [5 ]
Neumann, Robert [3 ]
Reynolds, Paul [5 ]
Sherman, Deb [6 ]
机构：
[1] Univ Colorado, Skaggs Sch Pharm, Aurora, CO USA
[2] Univ Tennessee, Coll Pharm, Memphis, TN USA
[3] Univ Colorado, Sch Med, Aurora, CO USA
[4] Univ Colorado Anschutz Med Campus, Denver, CO USA
[5] Univ Colorado Skaggs Sch Pharm, Denver, CO USA
[6] Univ Colorado Hosp, Aurora, CO USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
993
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CONCENTRATIONS OF CEFOTAXIME AND THE DESACETYL METABOLITE IN SERUM AND CSF OF PATIENTS WITH MENINGITIS
    HUMBERT, G
    LEROY, A
    NAIR, SR
    CHERUBIN, CE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (05) : 487 - 494
  • [22] PHARMACOKINETIC MODELING OF VANCOMYCIN SERUM AND CSF CONCENTRATIONS IN ICU PATIENTS
    Louie, Jessica
    Benefield, Russell
    Avedissian, Sean
    Ansari, Safdar
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 297 - 297
  • [23] Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis
    Johnson, TN
    Rostami-Hodjegan, A
    Goddard, JM
    Tanner, MS
    Tucker, GT
    BRITISH JOURNAL OF ANAESTHESIA, 2002, 89 (03) : 428 - 437
  • [24] Semiphysiologically Based Pharmacokinetic Model for Midazolam and CYP3A Mediated Metabolite 1-OH-Midazolam in Morbidly Obese and Weight Loss Surgery Patients
    Brill, M. J. E.
    Valitalo, P. A. J.
    Darwich, A. S.
    van Ramshorst, B.
    van Dongen, H. P. A.
    Rostami-Hodjegan, A.
    Danhof, M.
    Knibbe, C. A. J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (01): : 20 - 30
  • [25] Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients
    Boulieu, R
    Lehmann, B
    Salord, F
    Fisher, C
    Morlet, D
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (02) : 255 - 258
  • [26] Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients
    R. Boulieu
    B. Lehmann
    F. Salord
    C. Fisher
    D. Morlet
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 255 - 258
  • [27] Change in the concentrations of amino acids in CSF and serum of patients with essential tremor
    Mally, J
    Baranyi, M
    Vizi, ES
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (05) : 555 - 560
  • [28] INHIBITION OF HUMAN CYP3A CATALYZED 1'-HYDROXY MIDAZOLAM FORMATION BY KETOCONAZOLE, NIFEDIPINE, ERYTHROMYCIN, CIMETIDINE, AND NIZATIDINE
    WRIGHTON, SA
    RING, BJ
    PHARMACEUTICAL RESEARCH, 1994, 11 (06) : 921 - 924
  • [29] DETERMINATION OF MIDAZOLAM AND ITS UNCONJUGATED 1-HYDROXY METABOLITE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    LEHMANN, B
    BOULIEU, R
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (01): : 138 - 142
  • [30] Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro
    Ring, BJ
    Binkley, SN
    Roskos, L
    Wrighton, SA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 275 (03): : 1131 - 1135
12345